NCT04971590View on ClinicalTrials.gov

Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Systemic Lupus Erythematosus
Interventions
OTHER

Participant completed survey

Participants will be required to complete the participant survey.

OTHER

Medical chart review

Data will be collected from medical charts of participants.

Trial Locations (1)

Unknown

RECRUITING

GSK Investigational Site, Dubai

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04971590 - Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis | Biotech Hunter | Biotech Hunter